Prophylaxis against de novo hepatitis B or hepatitis B recurrence by vaccination for living-donor liver transplant recipients with hepatitis B-related disease: a pilot study
Not Applicable
- Conditions
- Hepatitis B, Living-donor liver transplantation recipient
- Registration Number
- JPRN-C000000259
- Lead Sponsor
- The Artificial Organ and Transplantation Division, Department of Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Positive for hepatitis C virus or human immunodeficiency virus. Patients on prophylactic lamivudine therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acquisition rate of active immunity following hepatitis B vaccination
- Secondary Outcome Measures
Name Time Method Dose reduction of anti-HBs immunoglobulin infusion after active immunization